バーテックス ファーマシューティカルズ インコーポレーテッド
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionHighTower Advisors, LLC
Latest Disclosed Ownership65,684 shares
Latest Disclosed Value $ 29,330,869
HighTower Advisors, LLC ownership in VRTX / Vertex Pharmaceuticals Incorporated

On May 5, 2026 - HighTower Advisors, LLC filed a 13F-HR form disclosing ownership of 65,684 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $29,330,533 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 47,559 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 38.11% during the quarter. The current value of the position is $29,349,582 USD.

HighTower Advisors, LLC has a history of taking positions in derivatives of the underlying security (VRTX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VRTX / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 65,684 18,125 38.11 29,331 36.03 0.0311
2026-02-06 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 47,559 3,544 8.05 21,561 25.09 0.0236
2025-11-07 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 44,015 -12,332 -21.89 17,238 -31.29 0.0196
2025-08-11 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 56,347 2,722 5.08 25,086 -3.51 0.0314
2025-05-13 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 53,625 5,039 10.37 25,999 32.88 0.0353
2025-02-07 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 48,586 -8,656 -15.12 19,566 -26.15 0.0268
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 57,242 4,148 7.81 26,494 7.16 0.0378
2024-08-13 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 53,094 -4,192 -7.32 24,724 3.11 0.0382
2024-05-06 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 57,286 -25,163 -30.52 23,978 -28.26 0.0388
2024-02-12 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 82,449 -6,045 -6.83 33,425 8.94 0.0561
2023-11-08 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 88,494 4,553 5.42 30,683 3.97 0.0577
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 83,941 22,918 37.56 29,510 53.12 0.0581
2023-05-12 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 61,023 -2,805 -4.39 19,272 4.58 0.0420
2023-02-09 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 63,828 13,869 27.76 18,428 27.29 0.0421
2022-11-09 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 49,959 -7,848 -13.58 14,477 -11.24 0.0388
2022-08-10 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 57,807 -36,502 -38.70 16,310 -33.78 0.0421
2022-05-12 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 94,309 29,446 45.40 24,629 73.44 0.0549
2022-02-10 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 64,863 11,205 20.88 14,200 46.50 0.0311
2021-11-12 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 53,658 40,274 300.91 9,693 259.93 0.0259
2021-08-06 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 13,384 -2,251 -14.40 2,693 -19.92 0.0078
2021-05-10 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 15,635 15,635 3,363 0.0106
2021-02-10 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -13,185 -100.00 0 -100.00
2020-11-13 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 13,185 1,806 15.87 3,590 8.62 0.0173
2020-08-10 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 11,379 1,410 14.14 3,305 38.92 0.0180
2020-05-21 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 9,969 -193 -1.90 2,379 6.92 0.0154
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 10,162 1,502 17.34 2,225 51.36 0.0131
2019-11-12 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 8,660 1,958 29.22 1,470 19.42 0.0080
2019-08-13 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 6,702 1,170 21.15 1,231 21.28 0.0073
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,532 -1,366 -19.80 1,015 -10.57 0.0068
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 6,898 -3,383 -32.91 1,135 -42.91 0.0087
2018-11-09 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 10,281 3,297 47.21 1,988 67.76 0.0143
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 6,984 274 4.08 1,185 8.52 0.0093
2018-05-15 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 6,710 -1,346 -16.71 1,092 -9.23 0.0091
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 8,056 -7,931 -49.61 1,203 -50.55 0.0099
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 15,987 -2,988 -15.75 2,433 -0.57 0.0208
2017-09-22 2017-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 18,975 588 3.20 2,447 21.62 0.0219
2017-08-14 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 18,975 588 2,447
2017-05-15 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 18,387 11,669 173.70 2,012 306.46 0.0193
2017-02-10 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 6,718 -1,836 -21.46 495 -33.82 0.0054
2016-11-14 2016-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 8,554 5,660 195.58 748 196.83 0.0087
2016-08-11 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,894 -3,826 -56.93 252 -52.63 0.0032
2016-05-16 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 6,720 -4,348 -39.28 532 -61.86 0.0017
2016-05-18 2015-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 11,068 7,514 211.42 1,395 278.05 0.0166
2016-02-12 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 11,068 1,395
2015-11-16 2015-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,554 -4,173 -54.01 369 -61.32 0.0049
2015-08-11 2015-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 7,727 -14,894 -65.84 954 -64.24 0.0153
2015-05-15 2015-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 22,621 -8,836 -28.09 2,668 -28.61 0.0397
2015-02-17 2014-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 31,457 -25,550 -44.82 3,737 -41.63 0.0572
2014-11-14 2014-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 57,007 -1,873 -3.18 6,402 14.83 0.1082
2014-08-13 2014-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 58,880 331 0.57 5,575 34.63 0.0967
2014-05-15 2014-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 58,549 52,796 917.71 4,141 869.79 0.0808
2014-02-14 2013-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,753 1,155 25.12 427 22.35 0.0088
2013-11-15 2013-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,598 554 13.70 349 7.72 0.0087
2013-08-14 2013-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,044 4,044 324 0.0088
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-13 2024-06-30 13F VERTEX PHARMACEUTICALS COM Call 100 4 n/a n/a n/a
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-12 2023-03-31 13F VERTEX PHARMACEUTICALS COM Call 100 1 n/a n/a n/a
2020-11-13 2020-09-30 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-10 2020-06-30 13F VERTEX PHARMACEUTICALS COM Call 700 3 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-13 2025-03-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 n/a n/a n/a
2025-02-07 2024-12-31 13F VERTEX PHARMACEUTICALS COM Put 100 1 n/a n/a n/a
2023-05-11 2023-03-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 n/a n/a n/a
2023-02-09 2022-12-31 13F VERTEX PHARMACEUTICALS COM Put 1 0.00 0 -100.00 n/a n/a n/a
2022-11-09 2022-09-30 13F VERTEX PHARMACEUTICALS COM Put 1 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.